Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial

Klein, AL; Lin, D; Cremer, PC; Nasir, S; Luis, SA; Abbate, A; Ertel, A; LeWinter, M; Beutler, A; Fang, F; Paolini, JF

Klein, AL (corresponding author), Cleveland Clin, Heart Vasc & Thorac Inst, Dept Cardiovasc Med, Ctr Diag & Treatment Pericardial Dis,Sect Cardiov, Cleveland, OH 44195 USA.

HEART, 2021; 107 (6): 488

Abstract

Objective Recurrent pericarditis (RP) incurs significant morbidity. Rilonacept inhibits both interleukin-1 alpha (IL-1 alpha) and IL-1 beta; these cyt......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索